Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of single-dose baloxavir marboxil for post-exposure prophylaxis of influenza in China
CTR20263343Phase 3Active
- Sponsor
- Roche
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Roche. Started Aug 2026; status: active.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20263343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263343.